AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Why did Rhythm Biosciences Ltd (ASX: RHY) soar over 100% on Wednesday?
May 17, 2023 07:22 PM AEST| By Neha SimpyRhythm Biosciences Limited (ASX: RHY) rose as much as 120% intraday and ended Wednesday, 17 May 2023, jumping by 95.714% to AU$0.685 after it updated that its product, ColoStat®, has secured UKCA Mark.
Healthy Returns: Investing in ASX Healthcare Stocks for Long-Term Growth
May 16, 2023 05:17 PM AEST| By Team Kalkine MediaInvesting in the stock market is a great way to build long-term wealth. One sector that has consistently performed well in the ASX is the healthcare sector. With a growing and aging population, the demand for healthcare services
NEU, TLX: Two ASX200 healthcare stocks with over 200% one-year gains
May 12, 2023 03:46 PM AEST| By Neha SimpyThe S&P/ASX200 healthcare index is up 9.87% in one year, as of Friday. Two healthcare companies- Neuren Pharmaceuticals Limited (ASX: NEU) and Telix Pharmaceuticals Limited (ASX: TLX), which have surpassed the index by rising 297% and 217.7%.
NEU, CUV: Why these two ASX healthcare stocks declined on Tuesday
May 09, 2023 06:53 PM AEST| By Neha SimpyThe the sub-sector S&P/ASX200 Healthcare index closed the day, plummeting by 0.57%. Also, Neuren Pharmaceuticals Limited (ASX: NEU) and Clinuvel Pharmaceuticals Limited (ASX: CUV) closed Tuesday’s trading session, plunging by 0.794% and 1.560%.
Sonic (ASX: SHL) to acquire Medical Laboratories Duesseldorf for AU$298m; shares fall
April 26, 2023 11:32 AM AEST| By Neha SimpyOn 26 April 2023, Sonic Healthcare Limited (ASX: SHL) notified that it had inked binding deals to acquire one of the leading clinical laboratories in Duesseldorf-based Medical Laboratories Duesseldorf (MLD).
Why is this ASX 200 stock up over 230% in the last one year?
April 12, 2023 09:40 AM AEST| By Neha SimpyThe S&P/ASX 200 is a benchmark index for the Australian stock market. It has declined 3.01% in the last one year period, as of Tuesday, 11 April 2023. Compared to it, in the same period, Neuren Pharmaceuticals Limited (ASX: NEU) has gained 231.79%.
ImpediMed (ASX: IPD): This ASX biotech stock almost doubles in a day. Here's why
March 27, 2023 09:19 PM AEDT| By Neha SimpyHighlights:,On Monday, ImpediMed Limited (ASX: IPD) announced an,updated NCCN Guidelines,®,to recommend frequent screening of lymphoedema with BIS.,The company has the only FDA-cleared BIS technology for the evaluation of lymphoedema.,In 2Q FY23, IPD...
This ASX healthcare company receives takeover offer from Bain Capital; shares jump
March 24, 2023 06:14 PM AEDT| By Neha SimpyThis ASX healthcare company receives takeover offer from Bain Capital; shares jump
Healius Limited (ASX: HLS) jumps over 9% on takeover bid from ACL
March 20, 2023 02:03 PM AEDT| By Neha SimpyHealius Limited (ASX: HLS) jumps over 9% on takeover bid from ACL
Neuren Pharmaceuticals’ (ASX:NEU) drug to treat Rett syndrome gets US FDA approval; shares up 20%
March 13, 2023 12:48 PM AEDT| By Priyabrata PrustyNeuren Pharmaceuticals’ (ASX:NEU) drug to treat Rett syndrome gets US FDA approval; shares up 20%
Mesoblast (ASX: MSB) shares rally 14% as FDA accepts resubmission of BLA for new therapy
March 08, 2023 06:12 PM AEDT| By Neha SimpyMesoblast Limited (ASX: MSB) share price skyrocketed after it updated that FDA had accepted its resubmission
Why are Rhythm Biosciences (ASX: RHY) shares down nearly 50% today
March 06, 2023 03:11 PM AEDT| By Neha SimpyRhythm Biosciences Limited (ASX: RHY) shares came under selling pressure and lost over half their market value on Monday
Mayne Pharma Group Ltd (ASX: MYX) surges 28% in 5 days. Here’s why
March 02, 2023 11:24 AM AEDT| By Versha JainMayne Pharma Group Limited (ASX: MYX) shares which closed with around 5% gain on 28 February, further jumped nearly 19% on Wednesday
Ramsay Health Care (ASX: RHC) profit rises 22.3% in half year 2023; shares end 3% higher
February 23, 2023 06:17 PM AEDT| By Neha SimpyRamsay Health Care Limited (ASX: RHC) reported 22.3% growth in its net profit and reported a 50 cents per share dividend (up 3.1% over pcp), sending its shares higher.
Cochlear (ASX: COH) HY23 revenue rises 9%, guidance maintained
February 15, 2023 06:01 PM AEDT| By Neha SimpyThe company reported a 9% jump in its revenue while maintaining net profit guidance for the current fiscal, leading to a sharp jump in its share price.
Why is Mayne Pharma Group (ASX:MYX) in limelight today?
January 18, 2023 01:37 PM AEDT| By Aditi Sarkar• The stock price of Mayne Pharma Group (ASX:MYX) touched its 52-week high of AU$3.80 on mid-day trading hours today.
Medibank (ASX:MPL) adds AU$207M to COVID-19 support fund
December 23, 2022 12:08 PM AEDT| By TamnnaShares of Medibank were trading in the red territory, 0.503% down on the ASX as of 11:35 AM AEDT, 23 December. The value of each Medibank share was AU$2.965 at the same time.
BWX (ASX:BWX) posts attributable loss of AU$337M
December 19, 2022 02:31 PM AEDT| By Sonal GoyalBWX has posted a loss of AU$335 million during the financial year 2022.
Know these ASX healthcare penny stocks
December 14, 2022 07:11 PM AEDT| By Aditi SarkarCU6, IMR, NSB and LCT are some of the ASX listed healthcare penny stocks that have registered decent price gains this month.
CSL (ASX:CSL) appoints next CEO and managing director, shares on watch
December 13, 2022 01:19 PM AEDT| By TamnnaOn 13 December 2022, Australian biotechnology company CSL Limited (ASX:CSL) announced the appointment of Dr Paul McKenzie as its new chief executive officer (CEO) and managing director.
Advertise your brand on Kalkine Media